Conversion from a calcineurin inhibitor to a sirolimus-based therapy after renal transplantation - An update of existing recommendations

被引:2
|
作者
Arns, W. [1 ]
Budde, K. [2 ]
Eitner, F. [3 ]
Gwinner, W. [4 ]
Hugo, C. [5 ]
Pressmar, K. [6 ]
Weimann, A. [7 ]
Witzke, O. [8 ]
机构
[1] Univ Witten Herdecke, Klinikum Koln Merheim, Med Klin Nephrol 1, Witten, Germany
[2] Charite Campus Mitte, Klin Nephrol, Berlin, Germany
[3] Klinikum RWTH Aachen, Med Klin 2, Aachen, Germany
[4] Hannover Med Sch, Klin Nieren & Hochdruckkrankheiten, D-30623 Hannover, Germany
[5] Nephrol Univ Klinikum Dresden, Med Klin & Poliklin 3, Dresden, Germany
[6] Univ Klinikum Erlangen, Med Klin Nephrol & Hypertensiol 4, Erlangen, Germany
[7] Univ Klinikum Leipzig, Chirurg Klin & Poliklin Transplantat Ambulanz 2, Leipzig, Germany
[8] Univ Duisburg Essen, Klin Nephrol, Univ Klinikum Essen, Duisburg, Germany
关键词
calcineurin inhibitor toxicity; mTOR inhibitor; sirolimus; chronic allograft nephropathy; EARLY CYCLOSPORINE WITHDRAWAL; ALLOGRAFT RECIPIENTS; KIDNEY-TRANSPLANTATION; MYCOPHENOLATE-MOFETIL; RAPAMYCIN INHIBITORS; MAINTENANCE THERAPY; PHASE-III; IMMUNOSUPPRESSION; EFFICACY; COMPLICATIONS;
D O I
10.1055/s-0031-1292822
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:2554 / 2559
页数:6
相关论文
共 50 条
  • [1] Recovery of Renal Function in Heart Transplantation Patients After Conversion From a Calcineurin Inhibitor-Based Therapy to Sirolimus
    Ayub-Ferreira, S. M.
    Avila, M. S.
    Feitosa, F. S.
    Souza, G. E. C.
    Mangini, S.
    Marcondes-Braga, F. G.
    Issa, V. S.
    Bacal, F.
    Chizzola, P. R.
    Cruz, F. D. D.
    Bocchi, E. A.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (02) : 542 - 544
  • [2] Sirolimus-based immunosuppression after cardiac transplantation: Predictors of recovery from calcineurin inhibitor-induced renal dysfunction
    Gustafsson, Finn
    Ross, Heather J.
    Delgado, Maria S.
    Bernabeo, Gustavo
    Delgado, Diego H.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2007, 26 (10): : 998 - 1003
  • [3] Comparison of sirolimus-based calcineurin inhibitor-sparing and calcineurin inhibitor-free regimens in cadaveric renal transplantation
    Lo, A
    Egidi, MF
    Gaber, LW
    Amiri, HS
    Vera, S
    Nezakatgoo, N
    Gaber, AS
    TRANSPLANTATION, 2004, 77 (08) : 1228 - 1235
  • [4] Calcineurin inhibitor withdrawal from sirolimus-based therapy in kidney transplantation: A systematic review of randomized trials
    Mulay, AV
    Hussain, N
    Fergusson, D
    Knoll, GA
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (07) : 1748 - 1756
  • [5] Calcineurin inhibitor withdrawal from sirolimus-based therapy in kidney transplantation: A systematic review of randomized trials
    Oberbauer, R
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (12) : 3023 - 3023
  • [6] Randomized Sirolimus-based Early Calcineurin Inhibitor Reduction in Liver Transplantation: Impact on Renal Function
    Buchholz, Bettina M.
    Ferguson, James W.
    Schnitzbauer, Andreas A.
    Nightingale, Peter
    Schlitt, Hans J.
    Geissler, Edward K.
    Mirza, Darius F.
    TRANSPLANTATION, 2020, 104 (05) : 1003 - 1018
  • [7] Protocol Conversion From a Calcineurin Inhibitor Based Therapy to Sirolimus
    Oberbauer, Rainer
    TRANSPLANTATION, 2009, 87 (08) : S7 - S10
  • [8] Conversion from calcineurin-inhibitor (CNI) based immunosuppression to Sirolimus in chronic CNI toxicity after renal transplantation
    Diekmann, F
    Waiser, J
    Einecke, G
    Dragun, D
    Fritsche, L
    Neumayer, HH
    Budde, K
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 364A - 364A
  • [9] Empiric switch from calcineurin inhibitor to sirolimus-based immunosuppression in pediatric heart transplantation recipients
    Loar, Robert W.
    Driscoll, David J.
    Kushwaha, Sudhir S.
    Cramer, Carl H.
    O'Leary, Patrick W.
    Daly, Richard C.
    Mauriello, Daniel A.
    Johnson, Jonathan N.
    PEDIATRIC TRANSPLANTATION, 2013, 17 (08) : 794 - 799
  • [10] DETERMINANTS OF PROTEINURIA AFTER CONVERSION FROM A CALCINEURIN INHIBITOR- TO SIROLIMUS-BASED IMMUNOSUPPRESSIVE REGIMEN: RESULTS FROM THE CONVERT TRIAL
    Pussell, B.
    Russ, G.
    Walker, R.
    O'Connell, P.
    Kanellis, J.
    Eris, J.
    NEPHROLOGY, 2006, 11 : A21 - A22